1.
Al-Rawashde FA, Alqaraleh M, Alhmoud JF, et al. In silico Evaluation of the Antileukemia Activities of Thymoquinone by Targeting FLT3-ITD and BCR-ABL Signaling in Myeloid leukemia. TJNPR. 2024;8(6):7447-7451. doi:10.26538/tjnpr/v8i6.17